Logo image of MASK

3 E NETWORK TECHNOLOGY GRP-A (MASK) Stock Fundamental Analysis

USA - NASDAQ:MASK - VGG8849D1107 - Common Stock

0.5714 USD
0 (-0.61%)
Last: 9/30/2025, 8:16:57 PM
0.7001 USD
+0.13 (+22.52%)
After Hours: 9/30/2025, 8:16:57 PM
Fundamental Rating

5

MASK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 87 industry peers in the IT Services industry. While MASK has a great health rating, its profitability is only average at the moment. MASK is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

MASK had positive earnings in the past year.
MASK had a positive operating cash flow in the past year.
MASK Yearly Net Income VS EBIT VS OCF VS FCFMASK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 500K 1M 1.5M

1.2 Ratios

Looking at the Return On Assets, with a value of 48.78%, MASK belongs to the top of the industry, outperforming 98.85% of the companies in the same industry.
MASK's Return On Equity of 69.00% is amongst the best of the industry. MASK outperforms 96.55% of its industry peers.
MASK has a Return On Invested Capital of 69.88%. This is amongst the best in the industry. MASK outperforms 98.85% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MASK is significantly above the industry average of 21.81%.
The last Return On Invested Capital (69.88%) for MASK is above the 3 year average (54.72%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 48.78%
ROE 69%
ROIC 69.88%
ROA(3y)38.06%
ROA(5y)N/A
ROE(3y)95.71%
ROE(5y)N/A
ROIC(3y)54.72%
ROIC(5y)N/A
MASK Yearly ROA, ROE, ROICMASK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 50 100

1.3 Margins

MASK has a better Profit Margin (34.04%) than 97.70% of its industry peers.
With an excellent Operating Margin value of 39.71%, MASK belongs to the best of the industry, outperforming 98.85% of the companies in the same industry.
The Gross Margin of MASK (50.69%) is better than 72.41% of its industry peers.
Industry RankSector Rank
OM 39.71%
PM (TTM) 34.04%
GM 50.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MASK Yearly Profit, Operating, Gross MarginsMASK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

MASK has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MASK has about the same amount of shares outstanding.
The debt/assets ratio for MASK has been reduced compared to a year ago.
MASK Yearly Shares OutstandingMASK Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M 10M
MASK Yearly Total Debt VS Total AssetsMASK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M

2.2 Solvency

An Altman-Z score of 7.19 indicates that MASK is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 7.19, MASK belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
The Debt to FCF ratio of MASK is 0.13, which is an excellent value as it means it would take MASK, only 0.13 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.13, MASK belongs to the best of the industry, outperforming 91.95% of the companies in the same industry.
MASK has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
MASK's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. MASK outperforms 77.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.13
Altman-Z 7.19
ROIC/WACC7.57
WACC9.23%
MASK Yearly LT Debt VS Equity VS FCFMASK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.3 Liquidity

MASK has a Current Ratio of 2.14. This indicates that MASK is financially healthy and has no problem in meeting its short term obligations.
MASK's Current ratio of 2.14 is fine compared to the rest of the industry. MASK outperforms 63.22% of its industry peers.
A Quick Ratio of 2.14 indicates that MASK has no problem at all paying its short term obligations.
MASK has a Quick ratio of 2.14. This is in the better half of the industry: MASK outperforms 64.37% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 2.14
MASK Yearly Current Assets VS Current LiabilitesMASK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

2

3. Growth

3.1 Past

MASK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.30%, which is quite impressive.
MASK shows a strong growth in Revenue. In the last year, the Revenue has grown by 172.94%.
EPS 1Y (TTM)55.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.65%
Revenue 1Y (TTM)172.94%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MASK Yearly Revenue VS EstimatesMASK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M 4M

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 2.48, the valuation of MASK can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of MASK indicates a rather cheap valuation: MASK is cheaper than 98.85% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.76. MASK is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 2.48
Fwd PE N/A
MASK Price Earnings VS Forward Price EarningsMASK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MASK is valued cheaply inside the industry as 98.85% of the companies are valued more expensively.
MASK's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MASK is cheaper than 97.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.77
EV/EBITDA 2.14
MASK Per share dataMASK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

The decent profitability rating of MASK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MASK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

3 E NETWORK TECHNOLOGY GRP-A

NASDAQ:MASK (9/30/2025, 8:16:57 PM)

After market: 0.7001 +0.13 (+22.52%)

0.5714

0 (-0.61%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.82%
Inst Owner ChangeN/A
Ins Owners68.44%
Ins Owner ChangeN/A
Market Cap6.43M
AnalystsN/A
Price TargetN/A
Short Float %2.03%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.48
Fwd PE N/A
P/S 0.84
P/FCF 5.77
P/OCF 5.77
P/B 1.69
P/tB 1.69
EV/EBITDA 2.14
EPS(TTM)0.23
EY40.25%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.1
FCFY17.33%
OCF(TTM)0.1
OCFY17.33%
SpS0.68
BVpS0.34
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 48.78%
ROE 69%
ROCE 78.73%
ROIC 69.88%
ROICexc 71.2%
ROICexgc 71.2%
OM 39.71%
PM (TTM) 34.04%
GM 50.69%
FCFM 14.49%
ROA(3y)38.06%
ROA(5y)N/A
ROE(3y)95.71%
ROE(5y)N/A
ROIC(3y)54.72%
ROIC(5y)N/A
ROICexc(3y)56.67%
ROICexc(5y)N/A
ROICexgc(3y)56.67%
ROICexgc(5y)N/A
ROCE(3y)61.65%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.13
Debt/EBITDA 0.03
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 36.41%
Profit Quality 42.57%
Current Ratio 2.14
Quick Ratio 2.14
Altman-Z 7.19
F-Score5
WACC9.23%
ROIC/WACC7.57
Cap/Depr(3y)97.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.14%
Cap/Sales(5y)N/A
Profit Quality(3y)109.93%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)172.94%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.48%
OCF growth 3YN/A
OCF growth 5YN/A